G. Fontaine, F. Fontaliran, and J. L. Hébert, Arrhythmogenic right ventricular dysplasia, Annu Rev Med, vol.50, pp.17-35, 1999.
URL : https://hal.archives-ouvertes.fr/hal-02330952

W. J. Mckenna, G. Thiene, and A. Nava, Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology, Br Heart J, vol.71, pp.215-218, 1994.

F. I. Marcus, W. J. Mckenna, and D. Sherrill, Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria, Circulation, vol.121, pp.1533-1541, 2010.

K. Yin, L. Ding, and Y. Li, Long-term follow-up of arrhythmogenic right ventricular cardiomyopathy patients with an implantable cardioverter-defibrillator for prevention of sudden cardiac death, Clin Cardiol, vol.40, pp.216-221, 2017.

L. Fabritz, M. G. Hoogendijk, and B. P. Scicluna, Load-reducing therapy prevents development of arrhythmogenic right ventricular cardiomyopathy in plakoglobin-deficient mice, J Am Coll Cardiol, vol.57, pp.740-750, 2011.

L. Gerche, A. Heidbüchel, H. Burns, and A. T. , Disproportionate exercise load and remodeling of the athlete's right ventricle, Med Sci Sports Exerc, vol.43, pp.974-981, 2011.

R. W. Campbell, ACE inhibitors and arrhythmias, Heart, vol.76, pp.79-82, 1996.

R. D. Fletcher, G. B. Cintron, and G. Johnson, The V-HeFT II VA Cooperative Studies Group. Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation, vol.87, pp.149-155, 1993.

F. I. Marcus, G. Fontaine, and G. Guiraudon, Right ventricular dysplasia: a report of 24 adult cases, Circulation, vol.65, pp.384-398, 1982.

G. Thiene, A. Nava, and D. Corrado, Right ventricular cardiomyopathy and sudden death in young people, N Engl J Med, vol.318, pp.129-133, 1988.

C. Basso, G. Thiene, and D. Corrado, Arrhythmogenic right ventricular cardiomyopathy: dysplasia, dystrophy or myocarditis?, Circulation, vol.94, pp.983-991, 1996.

G. Thiene and C. Basso, Arrhythmogenic right ventricular cardiomyopathy: an update, Cardiovasc Pathol, vol.10, pp.109-117, 2001.

G. Amati, O. Leone, and C. R. Di-gioia, Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns, Hum Pathol, vol.32, pp.1078-1086, 2001.

Q. Shi, J. Abusarah, and G. Baroudi, Ramipril attenuates lipid peroxidation and cardiac fibrosis in an experimental model of rheumatoid arthritis, Arthritis Res Ther, vol.18, p.223, 2012.

D. Grimm, E. P. Kromer, and W. Böcker, Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: effects of angiotensin converting enzyme inhibition, J Hypertens, vol.16, pp.1345-1355, 1998.

H. Cernecka, G. Doka, and J. Srankova, Ramipril restores PPAR?/? and PPAR? expressions and reduces cardiac NADPH oxidase but fails to restore cardiac function and accompanied myosin heavy-chain ratio shift in severe anthracycline-induced cardiomyopathy in rat, Eur J Pharmacol, vol.15, pp.244-253, 2016.

F. Djouadi, Y. Lecarpentier, and J. L. Hébert, A potential link between peroxisome proliferator-activated receptor signalling and the pathogenesis of arrhythmogenic right ventricular cardiomyopathy, Cardiovasc Res, vol.84, pp.83-90, 2009.

E. Morel, J. Drai, and P. Chevalier, Angiotensin-converting enzyme inhibitors can prevent myocardial deterioration, Heart Rhythm, vol.14, issue.5, 2017.

S. Yusuf, B. Pitt, and C. E. Davis, Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure, SOLVD Investigators, vol.325, pp.293-302, 1991.

A. Martin, J. Crawford, and J. R. Skinner, High arrhythmic burden but low mortality during long-term follow-up in arrhythmogenic right ventricular cardiomyopathy, Heart Lung Circ, vol.25, pp.275-281, 2016.

M. P. Riley, E. Zado, and R. Bala, Lack of uniform progression of endocardial scar in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy and ventricular tachycardia, Circ Arrhythm Electrophysiol, vol.3, pp.332-338, 2010.

D. Corrado, T. Wichter, and M. S. Link, Treatment of arrhythmogenic right ventricular cardiomyopathy/dysplasia: an international task force consensus statement, Eur Heart J, vol.36, pp.3227-3237, 2015.

E. Morel, A. W. Manati, and P. Nony, Blockade of the renin-angiotensin-aldosterone system in patients with arrhythmogenic right ventricular dysplasia: A double-blind, multicenter, prospective, randomized, genotypedriven study (BRAVE study), Clin Cardiol, vol.41, pp.300-306, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02490359

,